Two multiple sclerosis experts discuss long-term and real-world data with oral therapies in the treatment of relapsing-remitting multiple sclerosis (RRMS) that was presented at ACTRIMS 2022.
EP. 1: Relapsing-Remitting Multiple Sclerosis (RRMS) and Impact on Quality of Life
Drs Obeidat and Okai, 2 MS experts, discuss impact of relapsing-remitting multiple sclerosis (RRMS) on the quality of life of patients and caregivers.
EP. 2: Importance of Early Treatment Start in MS
Dr Okai explains why it is important to initiate MS treatment early and to stay compliant with the treatment.
EP. 3: Treatment Considerations in MS
Two MS experts discuss shared decision-making and other considerations in choosing MS treatment.
EP. 4: Oral Therapies in MS
Dr Okai provides an overview of oral DMTs available to patients with RRMS.
EP. 5: Monitoring and Risk Mitigation in MS
MS experts highlight the value of monitoring and use of risk mitigation strategies when taking care of patients with MS.
EP. 6: Long-Term Data With Oral DMTs in MS
Drs Obeidat and Okai discuss long-term data with oral DMTs that were recently presented at ACTRIMS 2022.
EP. 7: Real-World Data in RRMS With Oral Therapies
Two MS experts discuss how the field is benefiting from availability of real-world data, given the absence of head-to-head trials.
EP. 8: Newer Oral DMTs in Clinical Practice
Annette Okai, MD, FAAN, discusses how she is utilizing the newer oral therapies and treatment advances in her practice.
EP. 9: Emerging Treatments in MS
Drs Okai and Obeidat share their excitement about an emerging new drug class for the treatment of MS.
EP. 10: Vaccinations in MS
Two MS experts discuss use and efficacy of vaccinations in patients with MS, especially in patients who are on oral DMTs.
EP. 11: Clinical Pearls for MS Care
Drs Obeidat and Okai share clinical pearls for physicians taking care of patients with MS.
2 Commerce Drive Cranbury, NJ 08512